Pharmagen Inc (PHRX) financial statements (2021 and earlier)

Company profile

Business Address 9337 FRASER AVE.
SILVER SPRING, MD 20910
State of Incorp. NV
Fiscal Year End December 31
SIC 10 - Metal Mining (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments226323
Cash and cash equivalents226323
Receivables368636
Inventory, net of allowances, customer advances and progress billings137147
Inventory137147
Prepaid expense and other current assets282
Other undisclosed current assets149198
Total current assets:8791,586
Noncurrent Assets
Property, plant and equipment38391
Intangible assets, net (including goodwill)1,196
Goodwill 1,196
Other undisclosed noncurrent assets2025
Total noncurrent assets:4031,312
TOTAL ASSETS:1,2822,897
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,379779
Other undisclosed accounts payable and accrued liabilities1,379779
Debt770750
Derivative instruments and hedges, liabilities2,114 
Due to related parties191148
Other undisclosed current liabilities3,644757
Total current liabilities:8,0992,435
Noncurrent Liabilities
Long-term debt and lease obligation, including:5503
Long-term debt, excluding current maturities 503
Capital lease obligations42 
Other undisclosed long-term debt and lease obligation(38) 
Other undisclosed noncurrent liabilities7652,652
Total noncurrent liabilities:7703,155
Total liabilities:8,8695,589
Stockholders' equity
Stockholders' equity attributable to parent, including:(7,712)(2,692)
Preferred stock 3
Common stock434381
Additional paid in capital1,478166
Accumulated deficit(9,148)(3,148)
Other undisclosed stockholders' equity attributable to parent(475)(94)
Other undisclosed stockholders' equity125 
Total stockholders' equity:(7,587)(2,692)
TOTAL LIABILITIES AND EQUITY:1,2822,897

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Revenues4,8133,937
Revenue, net4,813323
Cost of revenue(1,768)(2,996)
Cost of goods and services sold(1,768)(2,996)
Other undisclosed gross profit 323
Gross profit:3,0451,265
Operating expenses(6,657)(3,361)
Other operating income (expense), net
(Other Expenses)
2,389(675)
Other undisclosed operating income (loss)(2,389)675
Operating loss:(3,612)(2,096)
Nonoperating income (expense)
(Investment Income, Nonoperating)
633(90)
Interest and debt expense(3,008)(245)
Loss before gain (loss) on sale of properties:(5,986)(2,431)
Other undisclosed net loss(14)(340)
Net loss:(6,001)(2,771)
Net loss attributable to noncontrolling interest(6,458) 
Other undisclosed net income attributable to parent6,458 
Net loss available to common stockholders, diluted:(6,001)(2,771)

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net loss:(6,001)(2,771)
Comprehensive loss:(6,001)(2,771)
Comprehensive income, net of tax, attributable to noncontrolling interest6,458 
Comprehensive income (loss), net of tax, attributable to parent:457(2,771)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: